Patient P-02501
Therapy response
Stable
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
20%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S14
- Day 15 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 15.
Primary contributors, last 14 days
- Inflammatory activity-11
- Nutritional resilience+11
- GI instability-10
- Toxicity-7
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable49 min
worsening · -4.3 vs previous 14 d
Sleep duration
Wearable7.7 h
stable · -0.0 vs previous 14 d
Energy level
Daily log6.1/10
stable · +0.1 vs previous 14 d
Steps
Wearable5,021
worsening · -476 vs previous 14 d
GI burden
Companion15.7/100
worsening · +9.4 vs previous 14 d
Adherence
Companion90.6 %
stable · -3.4 vs previous 14 d
Sleep quality
Wearable58.5/100
stable · -1.3 vs previous 14 d
Glucose, CGM daily mean
CGM118 mg/dL
stable · +3.4 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 76 from the failing basin, 23 from restoration.
Good elements to keep
- Protein (supports)perturbation · steering +5.5
- Proteinsupporter · GI -3.1 next day
Main detractors to watch
- Low butyrate capacityhidden · steering -17.5
- Dietary fat loadperturbation · steering -6
- Alcoholperturbation · steering -3.5
- Dietary fat loaddetractor · GI +3.2 next day
- Alcoholdetractor · GI +2 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Dietary fat load+3.2detractor · 95%
- Protein-3.1supporter · 95%
- Alcohol+2detractor · 76%
- Caffeine-1.5no signal · 48%
- Histamine load-0.4no signal · 15%
- Insoluble fibre-0.4no signal · 15%
- Ultra-processed food+0.2no signal · 15%
- Simple carbohydrates0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓35
- MicrobiomeButyrate capacity 40/100
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.1 · butyrate capacity 40/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 38 ms
- Sleep
- 7.0 h
- Steps
- 3,282
- Resting HR
- 58 bpm
Daily log: GI score 16, nutritional resilience 74, adherence 91.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.